Why should antibodies that show a narrow band for the molecular weight of the target antigen by Western blot be preferred in IHC?

Master the QIHC Exam. Utilize flashcards and multiple-choice questions equipped with hints and explanations. Excel in your immunohistochemistry qualification!

Multiple Choice

Why should antibodies that show a narrow band for the molecular weight of the target antigen by Western blot be preferred in IHC?

Explanation:
In IHC, you want staining that is truly from the target antigen with minimal background from other proteins. A narrow, single-band pattern on a Western blot shows the antibody binds mainly to one protein at its expected size and has little cross-reactivity to other proteins. That high specificity translates to cleaner, more reliable staining in tissue sections, because there’s less off-target binding contributing to background signal. The result is a higher signal-to-noise ratio, making it easier to discern where the antigen really is. Cost or production ease doesn’t guarantee this specificity, so cheaper antibodies aren’t automatically better for IHC. An antibody that binds a broader range of epitopes would likely cross-react with other proteins and tissues, increasing non-specific staining. And while blocking helps reduce background, the Western blot signal width itself doesn’t determine how much blocking you’ll need; the key point is the antibody’s proven specificity, which underpins a cleaner IHC performance.

In IHC, you want staining that is truly from the target antigen with minimal background from other proteins. A narrow, single-band pattern on a Western blot shows the antibody binds mainly to one protein at its expected size and has little cross-reactivity to other proteins. That high specificity translates to cleaner, more reliable staining in tissue sections, because there’s less off-target binding contributing to background signal. The result is a higher signal-to-noise ratio, making it easier to discern where the antigen really is.

Cost or production ease doesn’t guarantee this specificity, so cheaper antibodies aren’t automatically better for IHC. An antibody that binds a broader range of epitopes would likely cross-react with other proteins and tissues, increasing non-specific staining. And while blocking helps reduce background, the Western blot signal width itself doesn’t determine how much blocking you’ll need; the key point is the antibody’s proven specificity, which underpins a cleaner IHC performance.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy